# Study Assessing Safety and Immunogenicity of IC43 Vaccination Against Pseudomonas Aeruginosa in Healthy Volunteers

> **NCT00778388** · PHASE1 · COMPLETED · sponsor: **Valneva Austria GmbH** · enrollment: 157 (actual)

## Conditions studied

- Healthy

## Interventions

- **BIOLOGICAL:** IC43
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT00778388
- **Lead sponsor:** Valneva Austria GmbH
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2008-09
- **Primary completion:** 2009-09
- **Final completion:** 2009-09
- **Target enrollment:** 157 (ACTUAL)
- **Last updated:** 2012-10-19


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT00778388

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT00778388, "Study Assessing Safety and Immunogenicity of IC43 Vaccination Against Pseudomonas Aeruginosa in Healthy Volunteers". Retrieved via AI Analytics 2026-06-25 from https://api.ai-analytics.org/clinical/NCT00778388. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*